Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation

• Main Authors: Wasana Prasitsuebsai, Tim R. Cressey, Edmund Capparelli, Nirun Vanprapar, Keswadee Lapphra, Kulkanya Chokephaibulkit
• Format: Journal
• Published: 2018
• Subjects: Medicine
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84858800794&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/51921
• Institution: Chiang Mai University

We assessed the pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children while they were receiving nevirapine-containing fixed-dose combination tablets with rifampicin-based tuberculosis treatment and after discontinuation. The median age (range) was 9.7 (4.4-11.7) years. The nevir...